From the publisher of this report:
Amgen’s 2022 Biosimilar Trends Report is a point-in-time overview of key trends in the US biosimilars marketplace, and it is intended to be a resource to help stakeholders better understand the current and future state of the biosimilars marketplace, and key considerations related to the evolving
biosimilars landscape. The information provided in this report is for background and informational purposes only and is not intended to promote Amgen’s products or any other products.
View Report